Search

Author/Creator Peytavin, G

1. A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. (30th December 2014)

Authors:
Laouénan, C; Guedj, J; Peytavin, G; Nguyen, TH Tram; Lapalus, M; Khelifa‐Mouri, F; Boyer, N; Zoulim, F; Serfaty, L; Bronowicki, J‐P; Martinot‐Peignoux, M; Lada, O; Asselah, T; Dorival, C; Hézode, C; Carrat, F; Nicot, F; Marcellin, P; Mentré, F
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 4:Number 1(2015:Jan.)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CP-142 Antiretroviral therapy optimisation in multitreated hiv patients: clinical and pharmacoeconomic approach in the ecovir study. (25th February 2017)

Authors:
Durand, L; Valantin, MA; Ktorza, N; Lenclume, L; Peytavin, G; Wirden, M; Costagliola, D; Assoumou, L; Katlama, C; Patrick, T
Journal:
European journal of hospital pharmacy
Issue:
Volume 24(2017)Supplement 1
Page Start:
A64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Issue 10 (October 2020)

Authors:
Calmy, Alexandra; Tovar Sanchez, Tamara; Kouanfack, Charles; Mpoudi-Etame, Mireille; Leroy, Sandrine; Perrineau, Ségolène; Lantche Wandji, Martial; Tetsa Tata, Darius; Omgba Bassega, Pierette; Abong Bwenda, Thérèse; Varloteaux, Marie; Tongo, Marcel; Mpoudi-Ngolé, Eitel; Montoyo, Alice; Mercier, N...
Journal:
Lancet
Issue:
Volume 7:Issue 10(2020)
Page Start:
e677
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study. Issue 9 (26th April 2017)

Authors:
Gantner, P; Cuzin, L; Allavena, C; Cabie, A; Pugliese, P; Valantin, M‐A; Bani‐Sadr, F; Joly, V; Ferry, T; Poizot‐Martin, I; Garraffo, R; Peytavin, G; Fafi‐Kremer, S; Rey, D
Other Names:
Billaud E. investigator.; Biron C. investigator.; Bonnet B. investigator.; Bouchez S. investigator.; Boutoille D. investigator.; Brunet C. investigator.; Jovelin T. investigator.; Hall N. investigator.; Bernaud C. investigator.; Morineau P. investigator.; Reliquet V. investigator.; Aubry O. inves...
Journal:
HIV medicine
Issue:
Volume 18:Issue 9(2017:Oct.)
Page Start:
704
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection. (10th June 2021)

Authors:
Bachelard, A; Isernia, V; Vallois, D; Le Gac, S; Chalal, L; Landman, R; Damond, F; Descamps, D; Yazdanpanah, Y; Peytavin, G; Ghosn, J
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 76:Number 9(2021)
Page Start:
2484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice. (15th May 2020)

Authors:
Alain, S; Feghoul, L; Girault, S; Lepiller, Q; Frobert, E; Michonneau, D; Berceanu, A; Ducastelle-Lepretre, S; Tilloy, V; Guerin, E; Le Goff, J; Peytavin, G; Hantz, S
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 75:Number 8(2020)
Page Start:
2253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations. (9th July 2020)

Authors:
Palich, R; Wirden, M; Peytavin, G; Lê, M -P; Seang, S; Abdi, B; Schneider, L; Tubiana, R; Valantin, M -A; Paccoud, O; Soulié, C; Calvez, V; Katlama, C; Marcelin, A -G
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 75:Number 10(2020)
Page Start:
2981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing. (4th June 2018)

Authors:
Nguyen, T; Fofana, D B; Lê, M P; Charpentier, C; Peytavin, G; Wirden, M; Lambert-Niclot, S; Desire, N; Grude, M; Morand-Joubert, L; Flandre, P; Katlama, C; Descamps, D; Calvez, V; Todesco, E; Marcelin, A G
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 73:Number 9(2018)
Page Start:
2485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗